Ambee Pharmaceuticals (DHA:AMBEEPHA) Change In Receivables: BDT0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT788.90
View Full Analysis

What is Ambee Pharmaceuticals Change In Receivables?

Ambee Pharmaceuticals DHA:AMBEEPHA +1.54% 18 Change In Receivables is BDT0.00 Mil as of . 20. GuruFocus rates DHA:AMBEEPHA with a GF Score™ of 18/100.

Ambee Pharmaceuticals's change in receivables for the quarter that ended in . 20 was BDT0.00 Mil. It means Ambee Pharmaceuticals's Accounts Receivable stayed the same from . 20 to . 20 .

Ambee Pharmaceuticals's change in receivables for the fiscal year that ended in . 20 was BDT0.00 Mil. It means Ambee Pharmaceuticals's Accounts Receivable stayed the same from . 20 to . 20 .

Ambee Pharmaceuticals's Accounts Receivable for the quarter that ended in . 20 was BDT0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ambee Pharmaceuticals's liquidation value for the six months ended in . 20 was BDT0.00 Mil.

Ambee Pharmaceuticals  (DHA:AMBEEPHA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ambee Pharmaceuticals's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=/*91
=

2. In Ben Graham's calculation of liquidation value, Ambee Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Ambee Pharmaceuticals's liquidation value for the quarter that ended in . 20 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=-+0.75 * +0.5 *
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Change In Receivables Related Terms

Ambee Pharmaceuticals Change In Receivables Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Change In Receivables Chart

Ambee Pharmaceuticals Annual Data
Trend
Change In Receivables

Ambee Pharmaceuticals Semi-Annual Data
Change In Receivables
DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of BDT0.00 Mil mean?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a Change In Receivables of BDT0.00 Mil as of . 20. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Ambee Pharmaceuticals and its competitors.
Is Ambee Pharmaceuticals' Change In Receivables too high?
Ambee Pharmaceuticals' current Change In Receivables is BDT0.00 Mil. Overall, Ambee Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Ambee Pharmaceuticals' Change In Receivables compare to IMNPQ?
Ambee Pharmaceuticals' Change In Receivables of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Ambee Pharmaceuticals and its competitors. Ambee Pharmaceuticals's current Change In Receivables is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambee Pharmaceuticals stock overvalued right now?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a current Change In Receivables of BDT0.00 Mil. The current Change In Receivables is BDT0.00 Mil. Ambee Pharmaceuticals' overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Ambee Pharmaceuticals (DHA:AMBEEPHA), the current Change In Receivables is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT788.90
Price